Methods for Treating Disorders of Tissue Function by Restoration of Morphogenetic Field Connectivity: General Prior Art Disclosure
March 2026
in “
Zenodo (CERN European Organization for Nuclear Research)
”
This document establishes prior art for methods aimed at treating tissue function disorders by restoring gap-junction-mediated morphogenetic field connectivity. It identifies the primary mechanism behind a wide range of tissue dysfunctions as the disconnection of cell populations from intercellular bioelectric communication, which is independent of membrane voltage state and not targeted by current treatments. The document serves as the foundational prior art for related disclosures specifically addressing androgenic alopecia and age-related sexual dysfunction.